Literature DB >> 28688667

Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.

Yinan Ji1, Ningbin Luo2, Yi Jiang1, Qiuyun Li1, Wei Wei1, Huawei Yang1, Jianlun Liu3.   

Abstract

BACKGROUND: Indocyanine green (ICG) is widely used as a tracer in sentinel lymph node biopsy (SLNB) of patients with breast cancer. Whether SLNB performance can be improved by supplementing ICG with methylene blue dye remains controversial. This study compared the performance of SLNB when ICG was used alone or with blue dye.
MATERIALS AND METHODS: Consecutive patients with T1-3 primary breast cancer at our hospital were recruited into our study and randomized to undergo SLNB with ICG alone (n = 62) or with the combination of ICG and blue dye (n = 65). We compared the two methods in terms of identification rate, number and detection time of sentinel lymph nodes (SLNs) removed.
RESULTS: SLN identification rate were similar in the absence (95.2%) or presence of blue dye (98.5%, P = 0.578) but significantly, more average nodes were removed when blue dye was used (3.8 ± 1.5 versus 2.7 ± 1.2, P = 0.000), and the average time for detecting each SLN was significantly shorter (3.91 ± 1.87 versus 5.65 ± 2.95 min; P = 0.000). No patient in the study experienced severe adverse reactions or complications. Recurrence of axillary node was detected in one patient (1.6%) using ICG alone but not in any patients using ICG and blue dye.
CONCLUSIONS: The efficiency and sensitivity of SLNB can be improved by combining ICG with blue dye.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blue dye; Breast cancer; Indocyanine green; Sentinel lymph node biopsy

Mesh:

Substances:

Year:  2017        PMID: 28688667     DOI: 10.1016/j.jss.2017.03.038

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Comparison of indocyanine green fluorescence and methylene blue dye in the detection of sentinel lymph nodes in breast cancer.

Authors:  Zhenghui Wang; Yangyang Cui; Mingjie Zheng; Han Ge; Yue Huang; Jinghui Peng; Hui Xie; Shui Wang
Journal:  Gland Surg       Date:  2020-10

2.  Comparative study of indocyanine green combined with blue dye with methylene blue only and carbon nanoparticles only for sentinel lymph node biopsy in breast cancer.

Authors:  Xingsong Qin; Muwen Yang; Xinyu Zheng
Journal:  Ann Surg Treat Res       Date:  2019-06-26       Impact factor: 1.859

3.  A Prospective Self-Controlled Study of Indocyanine Green, Radioisotope, and Methylene Blue for Combined Imaging of Axillary Sentinel Lymph Nodes in Breast Cancer.

Authors:  Yuting Jin; Long Yuan; Yi Zhang; Peng Tang; Ying Yang; Linjun Fan; Li Chen; Xiaowei Qi; Jun Jiang
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

4.  Near-infrared laparoscopy with indocyanine green for axillary sentinel lymph node biopsy in early breast cancer: preliminary experience of a single unit.

Authors:  Ping Yang; Xi'e Hu; Shujia Peng; Lu Wang; Lin Yang; Yanming Dong; Zhenyu Yang; Lijuan Yuan; Huadong Zhao; Xianli He; Guoqiang Bao
Journal:  Gland Surg       Date:  2021-05

5.  Role of Indocyanine Green in Fluorescence Imaging with Near-Infrared Light to Identify Sentinel Lymph Nodes, Lymphatic Vessels and Pathways Prior to Surgery - A Critical Evaluation of Options.

Authors:  Andreas Hackethal; Markus Hirschburger; Sven Oliver Eicker; Thomas Mücke; Christoph Lindner; Olaf Buchweitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-01-22       Impact factor: 2.915

6.  The detection rate of methylene blue combined with another tracer in sentinel lymph node biopsy of early-stage breast cancer: a systematic review and network meta-analysis.

Authors:  Hong-Jin Liu; Ming-Shuai Sun; Li-Yuan Liu; Zheng-Heng Yu; Xiao-Xi Chen; Qian Liu; Yuan-Jia Cheng; Ling Xu; Yin-Hua Liu; Jing-Ming Ye
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.